ImmunoCellular Therapeutics Ltd (NYSEMKT:IMUC) announced that Andrew Gengos, Chief Executive Officer, will present a corporate overview and business update at the 16th Annual BIO CEO & Investor Conference at 1:30 pm ET on Monday, February 10, 2014, at the Waldorf Astoria Hotel in New York City. ImmunoCellular Therapeutics Ltd (NYSEMKT:IMUC) stock opened at $1.20 in last trading session, and closed at $1.12, trading in the range of $1.12 – $1.23. The stock showed a negative weekly performance of -8.20%.
Ariad Pharmaceuticals (NASDAQ:ARIA) was upgraded by research analysts at BMO Capital Markets to an “outperform” rating in a report released on Friday, Analyst Ratings.Net reports. Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) shares closed at $6.88 on last trade day, by losing -6.90%. Stock 52 week range is $2.15 – $23.00. Company’s market capitalization is $1.28 billion.
Merrimack Pharmaceuticals Inc (NASDAQ:MACK) average recommendation is Buy with average target price of $10.90. Merrimack Pharmaceuticals Inc (NASDAQ:MACK) stock decreased -8.57% and finished the last session at $4.80. The EPS of the stock remained -1.26. Company’s market capitalization is $491.27 billion.
Vical Incorporated (NASDAQ:VICL) average recommendation is overweight with average Target Price of $2.13. Vical Incorporated (NASDAQ:VICL) stock opened at $1.34 in last trading session and closed at $1.25. The 52 week range of the stock is $1.01 – $4.51 and the day range was $1.25 – $1.35.